Latest News from: Roswell Park Comprehensive Cancer Center

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 308

Article ID: 705116

Opioid Prescriptions Can Be Drastically Reduced After Surgery with No Increase in Pain, Study Shows Striking

Roswell Park Comprehensive Cancer Center

Pain after surgery can be effectively managed with minimal or no opioids, according to research conducted at Roswell Park Comprehensive Cancer Center and published today in JAMA Network Open. A two-year study by a multidisciplinary team of surgeons and other cancer specialists shows that the amount of opioid medications prescribed after surgery can be drastically reduced without negatively affecting pain scores, postoperative complications or patient requests for additional

Released:
7-Dec-2018 11:05 AM EST
FenstermakerandCiesielskiLab2012-08-2133.jpg

Article ID: 704536

Brain Cancer Immunotherapy SurVaxM Extends Survival, Even in Hard-to-Treat Patients

Roswell Park Comprehensive Cancer Center

The latest results from an ongoing clinical study incorporating the immunotherapy SurVaxM as part of combination treatment for glioblastoma show that this investigational drug is safe, well-tolerated and extended survival even among the hardest-to-treat subgroups of patients. The findings were presented at the Society for Neuro-Oncology Annual Meeting in New Orleans.

Released:
28-Nov-2018 11:05 AM EST
SabyGeorgeJanuary2520183.jpg

Article ID: 704427

Research Review Underscores Progress in Treating Kidney Cancer, Importance of Close Patient Monitoring

Roswell Park Comprehensive Cancer Center

In an effort to compile and summarize the latest knowledge about these immunotherapy combinations and their implications, a group of kidney cancer immunotherapy experts led by Saby George, MD, of Roswell Park Comprehensive Cancer Center have written a new research review article assessing current approaches to treating patients newly diagnosed with kidney cancer and also looking ahead to some of the most pressing questions still to be answered related to these emerging therapies. Published online Nov. 21 by the journal JAMA Oncology, the review article highlights the path to approval for the new standard of care for these patients — ipilimumab, also known as Yervoy, together with nivolumab, also known as Opdivo.

Released:
26-Nov-2018 5:05 PM EST
1200px-Pathway_through_Camptotheca_acuminata_-_Chengdu_Botanical_Garden_-_Chengdu_China_-_DSC03513.jpg

Article ID: 702398

Compound Derived From Chinese Tree Bark Shows Promise as Treatment for Pancreatic Cancer

Roswell Park Comprehensive Cancer Center

A new derivative of a compound found in the bark of a rare Chinese tree has powerful anticancer properties and a low toxicity profile, according to new research from a Roswell Park Comprehensive Cancer Center published in the Journal of Experimental & Clinical Cancer Research.

Released:
18-Oct-2018 7:00 AM EDT
JointVenturePhoto2.jpg

Article ID: 701168

Governor Cuomo Announces First-Ever Biotech Venture Between U.S. and Cuba to Research and Develop New Cancer Treatments

Roswell Park Comprehensive Cancer Center

Governor Andrew M. Cuomo today announced Buffalo-based Roswell Park Comprehensive Cancer Center has formed the Innovative Immunotherapy Alliance S.A., the first-ever biotech venture between the U.S. and Cuba.

Released:
26-Sep-2018 1:50 PM EDT
PhotofromMoonshotPressRelease_SmallerImage.jpg

Article ID: 701099

Roswell Park Awarded More Than $6 Million in Moonshot Funds to Lead New Data Management Resource

Roswell Park Comprehensive Cancer Center

Through a grant award provided by the Cancer MoonshotSM, Roswell Park Comprehensive Cancer Center will support and advance some of the nation’s most ambitious cancer research projects.

Released:
25-Sep-2018 2:40 PM EDT
Drs.MaciejGoniewiczandRichardOConnor_Image2_SmallerSize.jpg

Article ID: 700896

Roswell Park and URMC To Create $19 Million Research Program Focused on Flavored Tobacco

Roswell Park Comprehensive Cancer Center

The expertise of two regional research teams has earned a federal grant of nearly $20 million to create the nation’s first program dedicated to the study of flavored tobacco.

Released:
21-Sep-2018 7:40 AM EDT
ErnstoffMarcOctober042017.jpg

Article ID: 700453

New Immunotherapy Approach Found in “Superagonist” Interleukin-15 Complex

Roswell Park Comprehensive Cancer Center

A team led by Marc Ernstoff, MD, of Roswell Park Comprehensive Cancer Center found that a drug complex containing IL-15 is both safe and well tolerated in patients with advanced solid tumors.

Released:
12-Sep-2018 6:05 PM EDT
MaciejGoniewiczinTobaccoResearchLaboratory.jpg

Article ID: 700184

Adolescent Users of Juul, Other E-Cigarette Pods Exposed to Nearly As Much Nicotine as Smokers, Study Shows

Roswell Park Comprehensive Cancer Center

A new Roswell Park/Stony Brook Children's Hospital study reports striking findings: that young users of newer “pod” e-cigarette devices are absorbing nicotine at levels approaching nicotine exposure from traditional combustible cigarettes.

Released:
7-Sep-2018 9:45 AM EDT
TangDean-environmental.jpg

Article ID: 700078

Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment

Roswell Park Comprehensive Cancer Center

A Roswell Park-led research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target. Their findings were published in the journal Nature Communications.

Released:
6-Sep-2018 8:05 AM EDT

Showing results

110 of 308

Chat now!